Federated Hermes’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.8M Sell
383,869
-2,038,340
-84% -$475M 0.15% 150
2025
Q4
$501M Sell
2,422,209
-1,023,902
-30% -$202M 0.84% 17
2025
Q3
$639M Buy
3,446,111
+679,872
+25% +$116M 1.13% 8
2025
Q2
$423M Sell
2,766,239
-145,054
-5% -$22.3M 0.8% 17
2025
Q1
$483M Sell
2,911,293
-197,077
-6% -$30.8M 1.04% 11
2024
Q4
$450M Buy
3,108,370
+1,011,533
+48% +$157M 0.98% 11
2024
Q3
$340M Buy
2,096,837
+970,318
+86% +$155M 0.75% 23
2024
Q2
$165M Buy
1,126,519
+321,201
+40% +$47.8M 0.39% 52
2024
Q1
$127M Sell
805,318
-21,942
-3% -$3.49M 0.29% 80
2023
Q4
$130M Buy
827,260
+203,378
+33% +$31.2M 0.32% 67
2023
Q3
$97.2M Sell
623,882
-119,341
-16% -$19.7M 0.26% 84
2023
Q2
$123M Buy
743,223
+5,194
+0.7% +$838K 0.31% 69
2023
Q1
$114M Buy
738,029
+163,449
+28% +$26.4M 0.29% 71
2022
Q4
$101M Buy
574,580
+110,423
+24% +$19.1M 0.28% 65
2022
Q3
$75.8M Sell
464,157
-49,124
-10% -$8.31M 0.22% 105
2022
Q2
$91.1M Sell
513,281
-143,826
-22% -$25.6M 0.25% 96
2022
Q1
$116M Buy
657,107
+29,095
+5% +$4.95M 0.26% 96
2021
Q4
$107M Buy
628,012
+35,154
+6% +$5.76M 0.2% 139
2021
Q3
$95.7M Sell
592,858
-36,692
-6% -$6.26M 0.18% 156
2021
Q2
$104M Buy
629,550
+48,938
+8% +$8.1M 0.19% 141
2021
Q1
$95.4M Buy
580,612
+75,007
+15% +$12.1M 0.19% 148
2020
Q4
$79.6M Buy
505,605
+4,571
+0.9% +$675K 0.16% 160
2020
Q3
$74.6M Sell
501,034
-271,234
-35% -$40.1M 0.17% 138
2020
Q2
$109M Buy
772,268
+91,927
+14% +$13.4M 0.27% 82
2020
Q1
$89.2M Buy
680,341
+131,463
+24% +$18.7M 0.26% 84
2019
Q4
$80.1M Sell
548,878
-25,656
-4% -$3.48M 0.18% 138
2019
Q3
$74.3M Sell
574,534
-25,406
-4% -$3.35M 0.18% 128
2019
Q2
$83.6M Sell
599,940
-5,110
-0.8% -$707K 0.2% 115
2019
Q1
$84.6M Sell
605,050
-58,455
-9% -$7.83M 0.21% 101
2018
Q4
$85.6M Buy
663,505
+167,286
+34% +$23.3M 0.23% 88
2018
Q3
$68.6M Sell
496,219
-203,132
-29% -$27M 0.16% 145
2018
Q2
$84.9M Sell
699,351
-115,557
-14% -$14.4M 0.25% 87
2018
Q1
$104M Buy
814,908
+312,461
+62% +$42.2M 0.3% 67
2017
Q4
$70.2M Buy
502,447
+276,734
+123% +$38.5M 0.2% 100
2017
Q3
$29.3M Sell
225,713
-114,617
-34% -$15.2M 0.08% 202
2017
Q2
$45M Buy
340,330
+24,291
+8% +$3.1M 0.13% 133
2017
Q1
$39.4M Sell
316,039
-2,068,683
-87% -$247M 0.11% 159
2016
Q4
$275M Sell
2,384,722
-916,417
-28% -$106M 0.82% 20
2016
Q3
$390M Sell
3,301,139
-397,332
-11% -$48.2M 1.12% 21
2016
Q2
$449M Buy
3,698,471
+250,326
+7% +$28.4M 1.31% 19
2016
Q1
$373M Buy
3,448,145
+203,997
+6% +$21.1M 1.16% 17
2015
Q4
$333M Buy
3,244,148
+536,729
+20% +$54M 1.05% 18
2015
Q3
$253M Buy
2,707,419
+207,421
+8% +$20.1M 0.82% 22
2015
Q2
$244M Sell
2,499,998
-83,230
-3% -$8.33M 0.73% 23
2015
Q1
$260M Buy
2,583,228
+249,103
+11% +$25.3M 0.79% 22
2014
Q4
$244M Sell
2,334,125
-1,235,118
-35% -$130M 0.75% 24
2014
Q3
$380M Sell
3,569,243
-199,914
-5% -$20.7M 1.22% 16
2014
Q2
$394M Sell
3,769,157
-117,088
-3% -$11.8M 1.24% 16
2014
Q1
$382M Sell
3,886,245
-539,997
-12% -$50.1M 1.28% 14
2013
Q4
$405M Sell
4,426,242
-1,219,341
-22% -$112M 1.4% 11
2013
Q3
$489M Sell
5,645,583
-723,385
-11% -$64.9M 1.89% 9
2013
Q2
$547M Buy
+6,368,968
New +$540M 2.16% 6

Other funds holding JNJ

Federated Hermes's JNJ Position: Q1 2026 in Review

Federated Hermes reduced its Johnson & Johnson (JNJ) stake by 84% in Q1 2026, selling an estimated $475M and leaving 383,869 shares worth $93.8M. The position accounts for 0.15% of the portfolio, ranked #150.

Federated Hermes first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $639M in Q3 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Federated Hermes held 383,869 shares of Johnson & Johnson worth $93.8M as of Q1 2026.
  • Federated Hermes sold 2,038,340 Johnson & Johnson shares in Q1 2026, an estimated $475M.
  • Johnson & Johnson made up 0.15% of Federated Hermes's portfolio in Q1 2026, its #150 holding.
  • Federated Hermes first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Johnson & Johnson position peaked at $639M in Q3 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.